Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5′ long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: Implications for viral latency

Journal of Virology

Volumn 78, Issue 24, 2004, Pages 13848-13864

  Calomme, Claire ^a   Dekoninck, Ann ^a   Nizet, Séverine ^a   Adam, Emmanuelle ^a   Nguyên, Thi Liên Anh ^a   Van Den Broeke, Anne ^b   Willems, Luc ^c   Kettmann, Richard ^c   Burny, Arsène ^a   Van Lint, Carine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CRE RECOMBINASE; DEACETYLASE; DEACETYLASE INHIBITOR; ENZYME; ENZYME INHIBITOR; HISTONE H4; MAX PROTEIN; PROTEIN MAD; PROTEIN MSIN3; REPRESSOR PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ACETYLATION; ANIMAL CELL; ARTICLE; BOVINE LEUKEMIA VIRUS; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; E BOX ELEMENT; ENHANCER REGION; ENZYME ACTIVITY; EPISOME; GENE INDUCTION; GENE LOCATION; GENE MUTATION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LONG TERMINAL REPEAT; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROVIRUS; REPRESSOR GENE; STEREOSPECIFICITY; TRANSCRIPTION INITIATION; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS TRANSCRIPTION;

EID: 10044284512     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.24.13848-13864.2004     Document Type: Article

References (95)

1. Adam, E., P. Kerkhofs, M. Mammerickx, A. Burny, R. Kettman, and L. Willems. 1996. The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression. J. Virol. 70:1990-1999.
2. Adam, E., P. Kerkhofs, M. Mammerickx, R. Kettmann, A. Burny, L. Droogmans, and L. Willems. 1994. Involvement of the cyclic AMP-responsive element binding protein in bovine leukemia virus expression in vivo. J. Virol. 68:5845-5853.
3. Ahringer, J. 2000. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 16:351-356.
4. Arias, J., A. S. Alberts, P. Brindle, F. X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-229.
5. Ayer, D. E., C. D. Laherty, Q. A. Lawrence, A. P. Armstrong, and R. N. Eisenman. 1996. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16:5772-5781.
6. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
7. Bloom, J. C., V. K. Ganjam, and T. G. Gabuzda. 1980. Glucocorticoid receptors in peripheral blood lymphocytes from bovine leukemia virus-infected cows with persistent lymphocytosis. Cancer Res. 40:2240-2244.
8. Bloom, J. C., S. J. Kenyon, and T. G. Gabuzda. 1979. Glucocorticoid effects on peripheral blood lymphocytes in cows infected with bovine leukemia virus. Blood 53:899-912.
9. Boffa, L. C., G. Vidali, R. S. Mann, and V. G. Allfrey. 1978. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253:3364-3366.
10. Bousset, K., M. Henriksson, J. M. Luscher-Firzlaff, D. W. Litchfleld, and B. Luscher. 1993. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 8:3211-3220.
11. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
12. Breen, G. A., and E. M. Jordan. 1999. Transcriptional activation of the F(1)F(0) ATP synthase alpha-subunit initiator element by USF2 is mediated by p300. Biochim. Biophys. Acta 1428:169-176.
13. Brehm, A., S. J. Nielsen, E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1999. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 18:2449-2458.
14. Calomme, C., T. L. Nguyen, Y. de Launoit, V. Kiermer, L. Droogmans, A. Burny, and C. Van Lint. 2002. Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression. J. Biol. Chem. 277:8775-8789.
15. Candido, E. P., R. Reeves, and J. R. Davie. 1978. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14:105-113.
16. Chaudhary, J., and M. K. Skinner. 2001. Role of the transcriptional coactivator CBP/p300 in linking basic helix-loop-helix and CREB responses for follicle-stimulating hormone-mediated activation of the transferrin promoter in Sertoli cells. Biol. Reprod. 65:568-574.
17. Chen, H., M. Tini, and R. M. Evans. 2001. HATs on and beyond chromatin. Curr. Opin. Cell Biol. 13:218-224.
18. Cheung, P., C. D. Allis, and P. Sassone-Corsi. 2000. Signaling to chromatin through histone modifications. Cell 103:263-271.
19. Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
20. Coull, J. J., F. Romerio, J. M. Sun, J. L. Volker, K. M. Galvin, J. R. Davie, Y. Shi, U. Hansen, and D. M. Margolis. 2000. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74:6790-6799.
21. Dekoninck, A., C. Calomme, S. Nizet, Y. de Launoit, A. Burny, J. Ghysdael, and C. Van Lint. 2003. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat. Oncogene 22:2882-2896.
22. Derse, D. 1987. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. J. Virol. 61:2462-2471.
23. Dimitrov, S., M. C. Dasso, and A. P. Wolffe. 1994. Remodeling sperm chromatin in Xenopus laevis egg extracts: the role of core histone phosphorylation and linker histone B4 in chromatin assembly. J. Cell Biol. 126:591-601.
24. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
25. Eckner, R., J. W. Ludlow, N. L. Lill, E. Oldread, Z. Arany, N. Modjtahedi, J. A. DeCaprio, D. M. Livingston, and J. A. Morgan. 1996. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16:3454-3464.
26. Ego, T., Y. Ariumi, and K. Shimotohno. 2002. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. Oncogene 21:7241-7246.
27. Gottlicher, M., S. Minucci, P. Zhu, O. H. Kramer, A. Schimpf, S. Giavara, J. P. Sleeman, C. F. Lo, C. Nervi, P. G. Pelicci, and T. Heinzel. 2001. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20:6969-6978.
28. Grandori, C., S. M. Cowley, L. P. James, and R. N. Eisenman. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:653-699.
29. Gwack, Y., H. Byun, S. Hwang, C. Lim, and J. Choe. 2001. CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J. Virol. 75:1909-1917.
30. Harada, H., M. Kitagawa, N. Tanaka, H. Yamamoto, K. Harada, M. Ishihara, and T. Taniguchi. 1993. Anti-oncogenic and oncogenic potentials of interferon regulatory factors 1 and 2. Science 259:971-974.
31. Harrod, R., Y. L. Kuo, Y. Tang, Y. Yao, A. Vassilev, Y. Nakatani, and C. Z. Giam. 2000. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J. Biol. Chem. 275:11852-11857.
32. Hatama, S., K. Otake, M. Ohta, M. Kobayashi, K. Imakawa, A. Ikemoto, H. Okuyama, M. Mochizuki, T. Miyazawa, Y. Tohya, Y. Fujii, and E. Takahashi. 2001. Reactivation of feline foamy virus from a chronically infected feline renal cell line by trichostatin A. Virology 283:315-323.
33. He, G., and D. M. Margolis. 2002. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol. Cell. Biol. 22:2965-2973.
34. Hottiger, M. O., and G. J. Nabel. 1998. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol. 72:8252-8256.
35. Ito, K., P. J. Barnes, and I. M. Adcock. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20:6891-6903.
36. Jayachandra, S., K. G. Low, A. E. Thlick, J. Yu, P. D. Ling, Y. Chang, and P. S. Moore. 1999. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc. Natl. Acad. Sci. USA 96:11566-11571.
37. Jenkins, P. J., U. K. Binne, and P. J. Farrell. 2000. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74:710-720.
38. Kagoshima, M., T. Wilcke, K. Ho, L. Tsaprouni, P. J. Barnes, N. Punchard, and I. M. Adcock. 2001. Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. Eur. J. Pharmacol. 429:327-334.
39. Kashanchi, F., J. F. Duvall, R. P. Kwok, J. R. Lundblad, R. H. Goodman, and J. N. Brady. 1998. The coactivator CBP stimulates human T-cell lymphotrophic virus type I Tax transactivation in vitro. J. Biol. Chem. 273:34646-34652.
40. Katoh, I., Y. Yoshinaka, and Y. Ikawa. 1989. Bovine leukemia virus transactivator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF. EMBO J. 8:497-503.
41. Kawasaki, H., L. Schiltz, R. Chiu, K. Itakura, K. Taira, Y. Nakatani, and K. K. Yokoyama. 2000. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405:195-200.
42. Kiermer, V., C. Van Lint, D. Briclet, C. Vanhulle, R. Kettmann, E. Verdin, A. Burny, and L. Droogmans. 1998. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression. J. Virol. 72:5526-5534.
43. Kihara-Negishi, F., H. Yamamoto, M. Suzuki, T. Yamada, T. Sakurai, T. Tamura, and T. Oikawa. 2001. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression. Oncogene 20:6039-6047.
44. Kino, T., S. K. Nordeen, and G. P. Chrousos. 1999. Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300. J. Steroid Biochem. Mol. Biol. 70:15-25.
45. Kiss-Toth, E., S. Paca-uccaralertkun, I. Unk, and I. Boros. 1993. Member of the CREB/ATF protein family, but not CREB alpha plays an active role in BLV tax trans activation in vivo. Nucleic Acids Res. 21:3677-3682.
46. Lee, T. I., and R. A. Young. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77-137.
47. Lemasson, I., and J. K. Nyborg. 2001. Human T-cell leukemia virus type I tax repression of p73beta is mediated through competition for the C/H1 domain of CBP. J. Biol. Chem. 276:15720-15727.
48. Lemasson, I., N. J. Polakowski, P. J. Layhourn, and J. K. Nyborg. 2002. Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J. Biol. Chem. 277:49459-49465.
49. Li, M., B. Damania, X. Alvarez, V. Ogryzko, K. Ozato, and J. U. Jung. 2000. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol. Cell. Biol. 20:8254-8263.
50. Li, M., H. Lee, J. Guo, F. Neipel, B. Fleckenstein, K. Ozato, and J. U. Jung. 1998. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J. Virol. 72:5433-5440.
51. Liu, R., H. Liu, X. Chen, M. Kirby, P. O. Brown, and K. Zhao. 2001. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106:309-318.
52. Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85-88.
53. Mandolesi, G., S. Gargano, M. Pennuto, B. Illi, R. Molfetta, L. Soucek, L. Mosca, A. Levi, R. Jucker, and S. Nasi. 2002. NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction. FEBS Lett. 510:50-56.
54. Massari, M. E., and C. Murre. 2000. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20:429-440.
55. Massari, M. E., R. R. Rivera, J. R. Voland, M. W. Quong, T. M. Breit, J. J. van Dongen, O. de Smit, and C. Murre. 1998. Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol. Cell. Biol. 18:3130-3139.
56. Masumi, A., and K. Ozato. 2001. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment. J. Biol. Chem. 276:20973-20980.
57. Meier, J. L. 2001. Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J. Virol. 75:1581-1593.
58. Merezak, C., C. Pierreux, K. Adam, F. Lemaigre, G. G. Rousseau, C. Calomme, C. Van Lint, D. Christophe, P. Kerkhofs, A. Burny, R. Kettmann, and L. Willems. 2001. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J. Virol. 75:6977-6988.
59. Merezak, C., M. Reichert, C. Van Lint, P. Kerkhofs, D. Portetelle, L. Willems, and R. Kettmann. 2002. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J. Virol. 76:5034-5042.
60. Mestre, J. R., D. E. Rivadeneira, P. J. Mackrell, M. Duff, P. P. Stapleton, V. Mack-Strong, S. Maddali, G. P. Smyth, T. Tanabe, and J. M. Daly. 2001. Overlapping CRE and E-box promoter elements can independently regulate COX-2 gene transcription in macrophages. FEBS Lett. 496:147-151.
61. Michael, L. F., H. Asahara, A. I. Shulman, W. L. Kraus, and M. Montminy. 2000. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol. Cell. Biol. 20:1596-1603.
62. Miller, J. M., L. D. Miller, C. Olson, and K. G. Gillette. 1969. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J. Natl. Cancer Inst. 43:1297-1305.
63. Naar, A. M., B. D. Lemon, and R. Tjian. 2001. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70:475-501.
64. Nakamura, M., M. Niki, K. Ohtani, and K. Sugamura. 1989. Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. Nucleic Acids Res. 17:5207-5221.
65. Ng, H. H., and A. Bird. 2000. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25:121-126.
66. Niermann, G. L., and G. C. Buehring. 1997. Hormone regulation of bovine leukemia virus via the long terminal repeat. Virology 239:249-258.
67. Pan, L., T. A. Black, Q. Shi, C. A. Jones, N. Petrovic, J. Loudon, C. Kane, C. D. Sigmund, and K. W. Gross. 2001. Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J. Biol. Chem. 276:45530-45538.
68. Phiel, C. J., F. Zhang, E. Y. Huang, M. G. Guenther, M. A. Lazar, and P. S. Klein. 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276:36734-36741.
69. Radkov, S. A., R. Touitou, A. Brehm, M. Rowe, M. West, T. Kouzarides, and M. J. Allday. 1999. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol. 73:5688-5697.
70. Rourke, I. J., T. V. Hansen, C. Nerlov, J. F. Rehfeld, and F. C. Nielsen. 1999. Negative cooperativity between juxtaposed E-box and cAMP/TPA responsive elements in the cholecystokinin gene promoter. FEBS Lett. 448:15-18.
71. Rubinstein, Y. R., K. N. Proctor, M. Bergel, B. Murphy, and A. C. Johnson. 1998. Interferon regulatory factor-1 is a major regulator of epidermal growth factor receptor gene expression. FEBS Lett. 431:268-272.
72. Sandmeyer, S. B., L. J. Hansen, and D. L. Chalker. 1990. Integration specificity of retrotransposons and retroviruses. Annu. Rev. Genet. 24:491-518.
73. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777-786.
74. Schreiber-Agus, N., and R. A. DePinho. 1998. Repression by the Mad(Mxi1)-Sin3 complex. Bioessays 20:808-818.
75. Scoggin, K. E., A. Ulloa, and J. K. Nyborg. 2001. The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol. Cell. Biol. 21:5520-5530.
76. Seo, T., D. Lee, B. Lee, J. H. Chung, and J. Choe. 2000. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem. Biophys. Res. Commun. 270:23-27.
77. Sjoblom-Hallen, A., W. Yang, A. Jansson, and L. Rymo. 1999. Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure. J. Virol. 73:2983-2993.
78. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435-459.
79. Taniguchi, T. 1997. Transcription factors IRF-1 and IRF-2: linking the immune responses and tumor suppression. J. Cell. Physiol. 173:128-130.
80. Unk, I., E. Kiss-Toth, and I. Boros. 1994. Transcription factor AP-4 participates in activation of bovine leukemia virus long terminal repeat by p34 Tax. Nucleic Acids Res. 22:4872-4875.
81. Van den Broeke, A., C. Bagnis, M. Ciesiolka, Y. Cleuter, H. Gelderblom, P. Kerkhofs, P. Griebel, P. Mannoni, and A. Burny. 1999. In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene. J. Virol. 73:1054-1065.
82. Van der Vlag, J., J. L. den Blaauwen, R. G. Sewalt, R. van Driel, and A. P. Otte. 2000. Transcriptional repression mediated by polycomb group proteins and other chromatin-associated repressors is selectively blocked by insulators. J. Biol. Chem. 275:697-704.
83. Van Lint, C., S. Emiliani, M. Ott, and E. Verdin. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1112-1120.
84. Van Lint, C., J. Ghysdael, P. Paras, Jr., A. Burny, and E. Verdin. 1994. A transcriptional regulatory element is associated with a nuclease- hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68:2632-2648.
85. Vidali, G., L. C. Boffa, E. M. Bradbury, and V. G. Allfrey. 1978. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc. Natl. Acad. Sci. USA 75:2239-2243.
86. Wang, L., S. R. Grossman, and E. Kieff. 2000. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl. Acad. Sci. USA 97:430-435.
87. Willems, L., A. Burny, O. Dangoisse, D. Collete, F. Dequiedt, J. S. Gatot, P. Kerkhofs, L. Lefèbvre, C. Merezak, D. Portetelle, J. C. Twizere, and R. Kettmann. 1999. Bovine leukemia virus as a model for human T-cell leukemia virus. Curr. Top. Virol. 1:139-167.
88. Willems, L., R. Kettmann, G. Chen, D. Portetelle, A. Burny, and D. Derse. 1992. A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat. J. Virol. 66:766-772.
89. Willems, L., R. Kettmann, F. Dequiedt, D. Portetelle, V. Voneche, I. Cornil, P. Kerkhofs, A. Burny, and M. Mammerickx. 1993. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
90. Xiao, J., and G. C. Buehring. 1998. In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat. J. Virol. 72:5994-6003.
91. Yamamoto, H., F. Kihara-Negishi, T. Yamada, Y. Hashimoto, and T. Oikawa. 1999. Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP. Oncogene 18:1495-1501.
92. Yamamoto, H., F. Kihara-Negishi, T. Yamada, M. Suzuki, T. Nakano, and T. Oikawa. 2002. Interaction between the hematopoietic Ets transcription factor Spi-B and the coactivator CREB-binding protein associated with negative cross-talk with c-Myb. Cell Growth Differ. 13:69-75.
93. Yoshida, M., and T. Beppu. 1988. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp. Cell Res. 177:122-131.
94. Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174-17179.
95. Zerby, D., C. J. Chen, E. Poon, D. Lee, R. Shiekhattar, and P. M. Lieberman. 1999. The ammo-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol. Cell. Biol. 19:1617-1626.